Emma Guttman

Search results

• Emma Guttman-Yassky, MD, PhD: Pushing Atopic Dermatitis Forward at AAD 2023

  Emma Guttman

  17/03/23

  2 items of Media coverage

  Press/Media

• Emma Guttman-Yassky of Icahn School of Medicine Talks Developments in Atopic Dermatitis Treatment

  Emma Guttman

  17/03/23

  1 item of Media coverage

  Press/Media

• Investigators at Icahn School of Medicine at Mount Sinai Describe Findings in Atopic Dermatitis (The Evolving Landscape of Biologic Therapies for Atopic Dermatitis: Present and Future Perspective)

  Emma Guttman & Benjamin Ungar

  27/02/23

  1 item of Media coverage

  Press/Media

• The Medicine Is a Miracle, but Only if You Can Afford It

  Emma Guttman

  7/02/23 → 14/02/23

  4 items of Media coverage

  Press/Media

• Experts React to Approval of Pfizer’s CIBINQO for Teens with Refractory AD

  Emma Guttman & Peter Lio

  12/02/23

  1 item of Media coverage

  Press/Media

• The Medicine Is a Miracle -- but Only if You Can Afford It

  Emma Guttman

  7/02/23

  2 items of Media coverage

  Press/Media

• The medicine is a miracle, but only if you can afford it

  Emma Guttman

  7/02/23

  1 item of Media coverage

  Press/Media

• Mount Sinai Physician Promises $5 Million Bequest to Support the Kimberly and Eric J. Waldman Department of Dermatology

  Emma Guttman & Kenneth Edelson

  2/02/23

  1 item of Media coverage

  Press/Media

• Mount Sinai physician promises $5 million bequest to dermatology department

  Emma Guttman & Kenneth Edelson

  1/02/23

  1 item of Media coverage

  Press/Media

• Significant Improvements: A New, Promising Long-Term Treatment for Eczema

  Emma Guttman

  25/01/23

  1 item of Media coverage

  Press/Media

• As acquisitions dip and layoffs abound, New York's tech firms focus on pharma

  Emma Guttman & Kenneth Edelson

  25/01/23

  1 item of Media coverage

  Press/Media

• Mount Sinai Physician Pays It Forward: $5 Million Bequest Promised To Support The Kimberly And Eric J. Waldman Department Of Dermatology

  Emma Guttman & Kenneth Edelson

  25/01/23

  1 item of Media coverage

  Press/Media

• Mount Sinai Physician Pays It Forward: $5 Million Bequest Promised to Support the Kimberly and Eric J. Waldman Department of Dermatology.

  Emma Guttman & Kenneth Edelson

  24/01/23

  1 item of Media coverage

  Press/Media

• Mount Sinai Physician Pays It Forward: $5 Million Bequest Promised to Support the Kimberly and Eric J. Wa

  Emma Guttman & Kenneth Edelson

  24/01/23

  1 item of Media coverage

  Press/Media

• Mount Sinai Physician Pays It Forward: $5 Million Bequest Promised to Support the Kimberly and Eric J. Waldman Department of Dermatology

  Emma Guttman & Kenneth Edelson

  24/01/23

  54 items of Media coverage

  Press/Media

• Findings from Icahn School of Medicine at Mount Sinai Provides New Data on Atopic Dermatitis (Dupilumab Improves Clinical Scores In Children and Adolescents With Moderate To Severe Atopic Dermatitis: a Real-world, Single-center Study)

  Emma Guttman & Benjamin Ungar

  13/01/23

  1 item of Media coverage

  Press/Media

• Target RWE Launches 35 New Disease State Registries in Complex Indications with High Unmet Medical Needs and Rapidly Evolving Therapies

  Emma Guttman

  11/01/23 → 12/01/23

  146 items of Media coverage

  Press/Media

• Target RWE Launches 35 New Disease State Registries in Complex Indications with High Unmet Medical Needs and Rapidly..

  Emma Guttman

  11/01/23

  1 item of Media coverage

  Press/Media

• Target RWE Launches 35 New Disease State Registries In Complex Indications With High Unmet Medical Needs And Rapidly Evolving Therapies'

  Emma Guttman

  11/01/23

  1 item of Media coverage

  Press/Media

• Rocatinlimab Effective for Moderate-to-Severe Atopic Dermatitis

  Emma Guttman

  15/12/22 → 16/12/22

  86 items of Media coverage

  Press/Media

• Rocatinlimab Effective for Moderate-to-Severe Atopic Dermatitis; Lasting improvement seen for patients receiving anti-OX40 antibody rocatinlimab compared with placebo.

  Emma Guttman

  15/12/22

  1 item of Media coverage

  Press/Media

• Rocatinlimab shows promising long-term results for Moderate to Severe Atopic Dermatitis: Lancet

  Emma Guttman

  11/12/22

  1 item of Media coverage

  Press/Media

• New drug effective, safe in long-term treatment of moderate to severe atopic dermatitis

  Emma Guttman

  9/12/22

  1 item of Media coverage

  Press/Media

• Investigators from Icahn School of Medicine at Mount Sinai Have Reported New Data on Alopecia Areata (Scalp Biomarkers During Dupilumab Treatment Support Th2 Pathway Pathogenicity In Alopecia Areata)

  Emma Guttman & Ana Brandusa Pavel

  6/12/22

  1 item of Media coverage

  Press/Media

• Upadacitinib has ‘favorable’ benefit-risk profile for atopic dermatitis

  Emma Guttman

  7/11/22

  1 item of Media coverage

  Press/Media